Legal
Key facts
KSF and Charles C. Foti, Jr. notified investors in Capricor Therapeutics, Inc. about a class action…
Key facts
Capricor Therapeutics is identified as NasdaqGS: CAPR
Key facts
The lawsuit is pending in the U.S. District Court for the Southern District of California
Atlas Watchline
Kahn Swick & Foti said Capricor Therapeutics investors have until Sept. 28, 2026, to seek lead-plaintiff…